LAUREN SPERINGO: Open Payments
NPI 1093215378 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,600 in 72 payments from 24 companies in 2025. Trend: 2023 $479 · 2024 $1,500 · 2025 $1,600
Food & beverage: $1,576Education: $24
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $359 |
| Travere Therapeutics, Inc. | 11 | $209 |
| Otsuka America Pharmaceutical, Inc. | 9 | $205 |
| Novartis Pharmaceuticals Corporation | 6 | $160 |
| Alexion Pharmaceuticals, Inc. | 3 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $65 |
| Novo Nordisk Inc | 3 | $62 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $59 |
| Apellis Pharmaceuticals, Inc. | 1 | $58 |
| Aurinia Pharma U.S., Inc. | 2 | $40 |
Products named: RINVOQ, JYNARQUE, Filspari, Vanrafia, ULTOMIRIS, JARDIANCE, Ozempic, Kerendia.
Industry payments across CT — which companies pay providers there.
